Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model

Darren Shafren; Min Quah; Yvonne Wong; Robert HI Andtbacka; Howard L Kaufman; Gough G Au

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model

【24h】

Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model

机译：一种新型溶溶解免疫治疗剂，Cavatak（Coxsackievirus A21）和免疫检查点梗阻的组合显着降低了肿瘤生长，并改善了免疫司徒小鼠黑色素瘤模型的存活

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2014年第s3期|共页
作者
Darren Shafren; Min Quah; Yvonne Wong; Robert HI Andtbacka; Howard L Kaufman; Gough G Au;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge [J] . Min Yuan, Yvonne Wong, Gough Au, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：静脉输送的卡瓦塔克病毒（柯萨奇病毒A21）与免疫检查点封锁的组合可显着减少肿瘤的生长和肿瘤的再攻击
2. Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer [J] . Annels Nicola E., Mansfield David, Arif Mehreen, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第19期

机译：I次ICAM-1靶向免疫治疗性-COXSackeivirus A21（CVA21）作为溶于非肌肉侵袭性膀胱癌的溶瘤剂
3. Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice [J] . Shiyun Dai, Yun Lv, Weidong Xu, Cancer gene therapy . 2020,第12期

机译：编码光（TNFSF14）通过在免疫态态切割小鼠中激活4T1小鼠乳腺肿瘤模型中的抗肿瘤免疫应答，抑制肿瘤生长抑制肿瘤生长
4. Combination of PDT and a DNA demethylating agent produces anti-tumor immune response in a mouse tumor model [C] . Pawel Mroz, Michael R Hamblin World congress of the International Photodynamic Association . 2009

机译：PDT和DNA去甲基化剂的组合在小鼠肿瘤模型中产生抗肿瘤免疫应答
5. STAT2 in the regulation of tumor growth and antitumor effects of type I interferons in a mouse model of melanoma. [D] . Yue, Chanyu. 2013

机译：STAT2在黑色素瘤小鼠模型中调节肿瘤生长和I型干扰素的抗肿瘤作用。
6. Combination of a novel oncolytic immunotherapeutic agent CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model [O] . Darren Shafren, Min Quah, Yvonne Wong, 2014

机译：新型溶瘤免疫治疗剂CAVATAK（柯萨奇病毒A21）与免疫检查点阻滞剂的组合可显着降低肿瘤的生长并改善具有免疫能力的小鼠黑色素瘤模型的存活率
7. Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model [O] . 2014

机译：新型溶瘤免疫治疗剂CAVATAK（柯萨奇病毒A21）与免疫检查点阻断剂的结合可显着降低肿瘤的生长，并改善具有免疫能力的小鼠黑色素瘤模型的存活率

Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model

著录项

相似文献

相关主题

期刊订阅